BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 17882659)

  • 1. Effect of p63 expression on survival in oral squamous cell carcinoma.
    Lo Muzio L; Campisi G; Farina A; Rubini C; Pastore L; Giannone N; Colella G; Leonardi R; Carinci F
    Cancer Invest; 2007 Sep; 25(6):464-9. PubMed ID: 17882659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p63 overexpression associates with poor prognosis in head and neck squamous cell carcinoma.
    Lo Muzio L; Santarelli A; Caltabiano R; Rubini C; Pieramici T; Trevisiol L; Carinci F; Leonardi R; De Lillo A; Lanzafame S; Bufo P; Piattelli A
    Hum Pathol; 2005 Feb; 36(2):187-94. PubMed ID: 15754296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of p53 and p63 immunoexpression in oral squamous cell carcinoma.
    de Oliveira LR; Ribeiro-Silva A; Zucoloto S
    J Oral Pathol Med; 2007 Apr; 36(4):191-7. PubMed ID: 17391296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
    Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
    Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of p63 and p53 expression in upper urinary tract transitional cell carcinoma.
    Zigeuner R; Tsybrovskyy O; Ratschek M; Rehak P; Lipsky K; Langner C
    Urology; 2004 Jun; 63(6):1079-83. PubMed ID: 15183954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunodetection of GLUT1, p63 and phospho-histone H1 in invasive head and neck squamous carcinoma: correlation of immunohistochemical staining patterns with keratinization.
    Burstein DE; Nagi C; Kohtz DS; Lee L; Wang B
    Histopathology; 2006 May; 48(6):717-22. PubMed ID: 16681688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of p63 (TA and deltaN isoforms) in human primary well differentiated buccal carcinomas.
    Chen YK; Hsue SS; Lin LM
    Int J Oral Maxillofac Surg; 2004 Jul; 33(5):493-7. PubMed ID: 15183414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p21WAF1/CIP1 expression is a marker of poor prognosis in oral squamous cell carcinoma.
    Nemes JA; Nemes Z; Márton IJ
    J Oral Pathol Med; 2005 May; 34(5):274-9. PubMed ID: 15817070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of human telomerase reverse transcriptase (hTERT) protein is significantly associated with the progression, recurrence and prognosis of oral squamous cell carcinoma in Taiwan.
    Chen HH; Yu CH; Wang JT; Liu BY; Wang YP; Sun A; Tsai TC; Chiang CP
    Oral Oncol; 2007 Feb; 43(2):122-9. PubMed ID: 16798059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of p63 is associated with radiation resistance and prognosis in oral squamous cell carcinoma.
    Moergel M; Abt E; Stockinger M; Kunkel M
    Oral Oncol; 2010 Sep; 46(9):667-71. PubMed ID: 20656547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P-cadherin expression and survival rate in oral squamous cell carcinoma: an immunohistochemical study.
    Lo Muzio L; Campisi G; Farina A; Rubini C; Pannone G; Serpico R; Laino G; De Lillo A; Carinci F
    BMC Cancer; 2005 Jun; 5():63. PubMed ID: 15967043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors and survival analysis in a sample of oral squamous cell carcinoma patients.
    Oliveira LR; Ribeiro-Silva A; Costa JP; Simões AL; Matteo MA; Zucoloto S
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Nov; 106(5):685-95. PubMed ID: 18760943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of HSP27 in head and neck squamous cell carcinoma: a retrospective analysis of 57 tumours.
    Lo Muzio L; Campisi G; Farina A; Rubini C; Ferrari F; Falaschini S; Leonardi R; Carinci F; Stalbano S; De Rosa G
    Anticancer Res; 2006; 26(2B):1343-9. PubMed ID: 16619543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High stromal versican expression predicts unfavourable outcome in oral squamous cell carcinoma.
    Pukkila M; Kosunen A; Ropponen K; Virtaniemi J; Kellokoski J; Kumpulainen E; Pirinen R; Nuutinen J; Johansson R; Kosma VM
    J Clin Pathol; 2007 Mar; 60(3):267-72. PubMed ID: 16731595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced expression of p63 has prognostic implications for patients with esophageal squamous cell carcinoma.
    Takahashi Y; Noguchi T; Takeno S; Kimura Y; Okubo M; Kawahara K
    Oncol Rep; 2006 Feb; 15(2):323-8. PubMed ID: 16391849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of p63 protein and mRNA in oral epithelial dysplasia.
    Chen YK; Hsue SS; Lin LM
    J Oral Pathol Med; 2005 Apr; 34(4):232-9. PubMed ID: 15752259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E-cadherin loss and Delta Np73L expression in oral squamous cell carcinomas showing aggressive behavior.
    Foschini MP; Cocchi R; Morandi L; Marucci G; Pennesi MG; Righi A; Tosi AL; de Biase D; Pession A; Montebugnoli L
    Head Neck; 2008 Nov; 30(11):1475-82. PubMed ID: 18704970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nerve growth factor receptor (p75 NTR) and pattern of invasion predict poor prognosis in oral squamous cell carcinoma.
    Søland TM; Brusevold IJ; Koppang HS; Schenck K; Bryne M
    Histopathology; 2008 Jul; 53(1):62-72. PubMed ID: 18540978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of activated Akt expression in oral squamous cell carcinoma.
    Lim J; Kim JH; Paeng JY; Kim MJ; Hong SD; Lee JI; Hong SP
    J Clin Pathol; 2005 Nov; 58(11):1199-205. PubMed ID: 16254112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p63 is useful in the diagnosis of mammary metaplastic carcinomas.
    Tse GM; Tan PH; Chaiwun B; Putti TC; Lui PC; Tsang AK; Wong FC; Lo AW
    Pathology; 2006 Feb; 38(1):16-20. PubMed ID: 16484002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.